Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
The British Journal of Radiology|January 24, 2018
Practice patterns for the radical treatment of nasopharyngeal cancer by head and neck oncologists in the United KingdomImran Petkar, Shreerang Bhide, Kate Newbold, et al.
The Lancet. Diabetes & Endocrinology|December 4, 2018
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trialHakim-Moulay Dehbi, Ujjal Mallick, Jonathan Wadsley, et al.
Thyroid : Official Journal of the American Thyroid Association|December 4, 2025
A Systematic Review of Absorbed Doses and Response in Patients Treated with Radioiodine for Differentiated Thyroid CancerJan Taprogge, Iain Murray, Kate Newbold, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2013
Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancerLiam Welsh, Ceri Powell, Brenda Pratt, et al.
Frontiers in Oncology|October 7, 2021
Early-Stage Glottic Squamous Cell Carcinoma in the Era of Image-Guided RadiotherapyAmit Gupta, Kee Howe Wong, Kate Newbold, et al.
European Thyroid Journal|November 27, 2019
2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid CancerLaura Fugazzola, Rossella Elisei, Dagmar Fuhrer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysisPrasad Dandekar, Clive Harmer, Yolanda Barbachano, et al.
World Journal of Surgical Oncology|April 5, 2008
Thyroid cancer causing obstruction of the great veins in the neckSteve L Hyer, Prasad Dandekar, Kate Newbold, et al.
Current Cancer Drug Targets|March 6, 2010
The biology of the sodium iodide symporter and its potential for targeted gene deliveryMohan Hingorani, Christine Spitzweg, Georges Vassaux, et al.
Lancet (London, England)|April 6, 2023
Thyroid cancerDebbie W Chen, Brian H H Lang, Donald S A McLeod, et al.
Pageof 9